Shari Geffon, MBA

Shari Geffon, MBA, has a diverse and extensive work experience in the biotechnology and pharmaceutical industries. Shari currently serves as the Vice President of Program and Alliance Management at RAPT Therapeutics since December 2021. Prior to this, they were the Chief Operating Officer at renegade.bio from November 2020 to December 2021, where they also worked as a Chief Operating Officer Advisor from September 2020 to November 2020.

From July 2019 to November 2020, Shari Geffon worked at Aimmune Therapeutics as the Head of Project Management, Project and Portfolio Management. Before that, they held the position of Executive Director and Head of Program Management at Satsuma Pharmaceuticals, Inc. from October 2017 to July 2019.

Shari Geffon also gained valuable experience at Alkahest, Inc. as the Senior Director of Project Management in 2017 and as an Executive Consultant during their period of independent consulting from August 2016 to May 2017.

Their career also includes working at FibroGen as the Executive Director and Head of Program Management and R&D Writing from July 2008 to August 2016. Prior to that, they worked as the Global Senior Director of Organizational Effectiveness & Design at Stiefel Laboratories from June 2006 to July 2008.

Additionally, Shari Geffon has held notable positions such as Senior Director of Project Management at Connetics and Senior Director of Project Management at Abgenix in the years 2006 and 2005, respectively.

Overall, Shari Geffon's work experience demonstrates their expertise in program and alliance management, project management, and leadership roles in the biotechnology and pharmaceutical industries.

Shari Geffon, MBA, completed their Bachelor of Science degree in Biological Sciences and Sociology from California State University, Chico, from 1986 to 1990. Later, they pursued a Master of Business Administration degree in International Business Administration at the University of Phoenix, from 1998 to 2000.